Medplus Health Services Limited has announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license for a store located in Nashik, Maharashtra. The suspension is for a period of five days. This action was taken by the Asst. Commissioner & Licensing authority, Food & Drug Administrations, MH, Nashik, Maharashtra. The order, received on May 06, 2026, pertains to alleged violations under Rule 65 of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of approximately ₹0.75 lakh due to this five-day suspension. The details of this matter will be made available on the company's website and the websites of BSE Limited and the National Stock Exchange of India Ltd.
